Paolo Tarantino

Dana-Farber Cancer Institute

Paolo Tarantino is listed as Dana-Farber Cancer Institute. Paolo is scheduled to speak at EORTC-NCI-AACR Symposium 2026 (ENA 2026) on 19 November 2026.

Compiled from published conference agendas; not yet confirmed by Paolo. Is this you? Claim this profile.

About

Paolo Tarantino is a breast medical oncologist and clinical researcher. He’s currently pursuing an advanced research fellowship at Dana-Farber Cancer Institute and at Harvard Medical School (Boston, MA) and a PhD in clinical research at the University of Milan. His research focuses on the study of the HER2 oncoprotein, the biology of HER2-low breast tumors and the development of novel antibody-drug conjugates.

Upcoming

EORTC-NCI-AACR Symposium 2026 (ENA 2026) 18 November 2026 – 20 November 2026

Plenary Session 4: Antibody-Drug Conjugates (ADCs) Speaker · 19 November 2026